Clinical Trial

COPD Exacerbation Follow Up

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-08-07; most recent amendment 2026-06-02.
Status change: Not Yet Recruiting → Recruiting 2026-03-26
Trial Details
NCT Number NCT07118306
Lead Sponsor Viz.ai, Inc.
Collaborators: Sanofi, Regeneron Pharmaceuticals
Conditions COPD (Chronic Obstructive Pulmonary Disease)
Enrollment 485 participants
Start Date 2026-02-27
Primary Completion 2027-07 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-03